17 results
Treatment options for patients with Chronic Symptomatic Systolic Heart Failure

#sCHF #CongestiveHeartFailure #Systolic #HFrEF #Algorithm #Management #Cardiology
Treatment options ... CongestiveHeartFailure #Systolic #HFrEF ... #Algorithm #Management ... #Cardiology #ivabradine
Algorithm for screening/diagnosis and treatment/follow‐up of iron deficiency in patients with chronic heart failure. Hb, haemoglobin;
Algorithm for screening ... /diagnosis and treatment ... , haemoglobin; HFrEF ... #HeartFailure #Cardiology ... #Indications #Treatment
Iron Deficiency in Heart Failure - Diagnosis and Treatment Algorithm
Diagnosis: Ferritin <100 ng/mL (absolute ID) OR
Diagnosis and Treatment ... Algorithm Diagnosis ... patients with HFrEF ... deficiency #CHF #HFrEF ... #cardiology #treatment
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
heart failure; HFpEF ... ejection fraction; HFrEF ... ventricular hypertrophy; MCS ... Stages #ACCAHA #Algorithm ... #Management #Cardiology
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
American College of Cardiology ... Society of America #HFrEF ... guideline #ACCAHA2017 #cardiology ... #treatment #algorithm
Heart Failure (HFrEF) Treatment - GDMT for stage C 

For patients with Heart Failure with REDUCED
Heart Failure (HFrEF ... ) Treatment - GDMT ... #Pharmacology # ... Management #Treatment ... #StageC #Cardiology
Iron Deficiency in Heart Failure
Pathophysiology:
Chronic heart failure leads to an increase in inflammatory cytokines → Inflammation
Ferritin <100 ng/mL ... Ferritin 100-299 ng/mL ... functional ID) Treatment ... deficiency #CHF #HFrEF ... diagnosis #management #cardiology
Algorithm for the Treatment of Uremic Pruritus
Nonpharmacologic Treatments:
 • Daily topical emollient
 • Avoidance of extremes
Algorithm for the ... Treatment of Uremic ... Evidence-Based Off-Label Pharmacologic ... nalfurafine 2.5 mcg ... uremia #itching #Algorithm
IDSA Recommendations for Preventing and Treating Penicillium marneffei Infections in HIV-AIDS
Preventing 1st Episode of Penicilliosis (Primary
IDSA Recommendations ... 100 cells/mm3 g/mL ... Penicilliosis #IDSA ... #Prevention #Treatment ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... suspension 4–6 mL ... for effective treatment ... candida #mucosal #IDSA ... infections #HIVAIDS #pharmacology